AlzeCure Pharma ABOSTO:ALZCUR -2.84%24 FCF Yield % is -5.14 as of Jul. 13, 2026. GuruFocus rates OSTO:ALZCUR with a GF Score™ of 24/100. The stock has 1 warning sign investors should review. Among 1,409 Biotechnology companies, AlzeCure Pharma AB ranks better than 62.03% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
AlzeCure Pharma AB FCF Yield % Related Terms
AlzeCure Pharma AB FCF Yield % Historical Data
* Premium members only.
The historical data trend for AlzeCure Pharma AB's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ALZCUR vs VRTX, REGN, ALNY: FCF Yield % Comparison
For the Biotechnology subindustry, AlzeCure Pharma AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AlzeCure Pharma AB FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, AlzeCure Pharma AB's FCF Yield % distribution charts can be found below:
* The bar in red indicates where AlzeCure Pharma AB's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AlzeCure Pharma AB (OSTO:ALZCUR) has a FCF Yield % of -5.14 as of Jul. 13, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on AlzeCure Pharma AB and its competitors. According to the industry distribution chart, AlzeCure Pharma AB ranks #535 out of 1409 companies in the Biotechnology industry, placing it in the top 38%.
Is AlzeCure Pharma AB's FCF Yield % too high?
AlzeCure Pharma AB's current FCF Yield % is -5.14. Based on the distribution chart, AlzeCure Pharma AB ranks #535 out of 1409 companies in the Biotechnology industry, which is above the industry midpoint. Overall, AlzeCure Pharma AB has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does AlzeCure Pharma AB's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, AlzeCure Pharma AB ranks #535 out of 1409 companies for FCF Yield %. This puts AlzeCure Pharma AB in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on AlzeCure Pharma AB and its competitors. AlzeCure Pharma AB's current FCF Yield % is -5.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AlzeCure Pharma AB stock overvalued right now?
AlzeCure Pharma AB (OSTO:ALZCUR) has a current FCF Yield % of -5.14. The current FCF Yield % is -5.14. AlzeCure Pharma AB's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For AlzeCure Pharma AB (OSTO:ALZCUR), the current FCF Yield % is -5.14 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in drug research with a primary focus on Alzheimer's disease. The company develops several drugs within its three research platforms, NeuroRestore, Alzstatin, and Painless. The company's drug candidates include: ACD440, which is in the clinical development phase for the treatment of neuropathic pain, ACD856, ACD857, and ACD680 for the treatment of Alzheimer's disease, and ACD137 for the treatment of severe pain in conditions such as osteoarthritis.
24GF Score
Get the complete analysis for OSTO:ALZCUR
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ALZCUR has been successfully added to your 
